Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2020 Nov 1.
Published in final edited form as: AIDS Care. 2019 Mar 7;31(11):1348–1352. doi: 10.1080/09540121.2019.1587355

Characteristics associated with perceived interrelations of pain and smoking among people living with HIV.

Hannah Esan 1, Josh Agress 2, Elizabeth K Seng 1,3,4, Jonathan Shuter 5,6, Andrea H Weinberger 1,5
PMCID: PMC6732051  NIHMSID: NIHMS1523261  PMID: 30843727

Abstract

Persons living with HIV/AIDS (PLWH) have very high prevalences of both cigarette smoking and pain, yet little is known about the relationship between smoking and pain for PLWH. The current study examines the perceived interrelations between pain and smoking and participant characteristics (i.e., demographics, heavier versus lighter smoking, current pain severity, depression, anxiety symptoms) in a sample of 101 current cigarette smoking adult PLWH in the Bronx, New York. Participants completed assessments of demographics, smoking behaviors, psychiatric symptoms, and pain severity. Interrelations of pain and smoking were measured using the 9-item Pain and Smoking Inventory (PSI) total score and three domain scores (pain as a motivator for smoking, smoking to cope with pain, and pain as a barrier for smoking cessation). Significant associations were found between greater current pain severity and greater endorsement of overall perceived interrelations between pain and smoking, pain as a motivator for smoking, and smoking to cope with pain. Greater anxiety symptoms were significantly associated with greater endorsement of overall perceived interrelations between pain and smoking, pain as a motivator for smoking, and smoking to cope with pain. Understanding the perceived relations between smoking and pain, as well as associated factors such as anxiety and pain severity, may help to guide interventions for PLWH who smoke in order to reduce the high prevalence of smoking and significant smoking-related health consequences.

Keywords: Smoking, Cigarettes, HIV, Pain, Anxiety

Introduction

Cigarette smoking is the leading preventable cause of mortality and morbidity in the United States (US; USDHHS, 2014). Persons living with HIV/AIDS (PLWH) smoke cigarettes at high prevalences (CDC, 2009, 2015; Mdodo et al., 2015; Park, Hernandez-Ramirez, Silverberg, Crothers, & Dubrow, 2016; USDHHS, 2014) and smoking can increase HIV symptom severity and the progression of HIV (CDC, 2015).

PLWH report high prevalences of chronic pain (Merlin, Bulls, Vucovich, Edelman, & Starrels, 2016; Merlin et al., 2012; Parker, Stein, & Jelsma, 2014) as do smokers (Ditre, Kosiba, Zale, Zvolensky, & Maisto, 2016; Ditre, Zale, Heckman, & Hendricks, 2017; Orhurhu, Pittelkow, & Hooten, 2015). Furthermore, those who report chronic pain report higher prevalences of smoking than those without pain (Orhurhu, Pittelkow, & Hooten, 2015; Patterson et al., 2012).

Despite the co-report of smoking and pain, little is known about association between smoking and pain among PLWH. This study examined the perceived interrelations between pain and smoking and participant characteristics (e.g., demographics) in a sample of current cigarette smoking adult PLWH.

Materials and Methods

Participants

Participants were PLWH receiving care at the Montefiore Medical Center’s Center for Positive Living (CPL) in the Bronx, New York. Inclusion criteria were: (1) a reported diagnosis of HIV and/or AIDS (2) capacity to give informed consent, (3) age 18 years or older, (4) English-speaking, and (5) current cigarette smoking (i.e., one or more cigarettes self-reported in the past day).

Procedure

All aspects of the study were approved by the Albert Einstein College of Medicine IRB. Following oral consent procedures, participants completed a paper survey (see measures below) and received a Target gift card. See (Weinberger, Seng, Ditre, Willoughby, & Shuter, 2018) for additional details about the study methodology.

Measures/Assessments

Demographics

Gender, race, ethnicity, sexual orientation, and education were assessed as categorical variables; age and years since HIV diagnosis were assessed as continuous variables.

Smoking

Participants were asked to report cigarette smoking frequency (days per week), number of cigarettes smoked per day (CPD), and use of non-cigarette tobacco products. Participants smoking 11 or more CPD were categorized as heavy smokers while those smoking 1-10 CPD were categorized as light smokers based on previous literature (e.g., Schane, Ling, & Glantz, 2010; Warner, 2015; Yi, Mayorga, Hassmiller Lich, & Pearson, 2017).

Anxiety

Anxiety symptoms were assessed using the Patient-Reported Outcomes Measurement Information System (PROMIS) for Anxiety Short Form-8A which is an 8-item questionnaire that is scored using a 5-point Likert scale (1=never to 5=always). Raw scores ranged from 8-40 and were converted into T-scores (i.e., a standardized score with a mean of 50 and a SD of 10; Levin et al., 2015). The PROMIS has demonstrated good internal consistency reliability (αs=0.93-0.96; Cella et al, 2010; Pilkonis et al., 2011).

Depression

The PROMIS for Depression-short form-8A was administered to assess depression symptoms. It is an 8-item questionnaire that is scored using a 5-point Likert scale (1=never to 5=always; Cella et al., 2010; Pilkonis et al., 2011). The raw scores (i.e., sum of all items; range 8-40) were converted into T-score using the PROMIS online system. Given the high correlation between the short form and the full-item bank (r=0.95, p<0.01), the short form was utilized in our analyses. Cronbach’s α for each measure ranged from 0.77 to 0.90 (Levin et al., 2015).

Pain

The Numeric Pain Rating Scale (NPRS) assessed past-seven day pain severity on an 11-point Likert scale (0=no pain, 10=most severe pain). The NPRS has excellent test–retest reliability (r=0.95-0.96) and high construct validity with other measure of pain (rs=0.86-0.95; Ferraz et al., 1990; Hawker, Mian, Kendzerska, & French, 2011).

Pain and Smoking Inventory

The Pain and Smoking Inventory (PSI) is a 9-item questionnaire measuring perceived interrelations of pain and smoking using a seven-point Likert scale (0=not true at all, 6=extremely true). The PSI includes a total score and three domains with three items each: (1) pain as a motivator of smoking, (2) smoking to cope with pain, and (3) pain as a barrier to smoking. Higher scores indicate greater endorsement of each domain. The PSI has demonstrated excellent internal consistency reliability for the total score and the three domains in a community sample (αs = 0.84-0.95; Ditre, Zale, Heckman, & Hendricks, 2017) and in the current study (αs = 0.92-0.95; Weinberger, Seng, Ditre, Willoughby, & Shuter, 2018). With regard to missing data, if one question was missing, the researchers averaged the other two questions from that domain. If there was more than one missing item, the data from that participant were excluded from the analyses (Ditre, personal communication, May 9, 2017).

Statistical Analysis

All statistics were performed using the Statistical Package for the Social Sciences (SPSS)-22.0. Heavy and light smokers were compared on participant characteristics using t-tests for continuous variable and chi-squares for categorical variables. In a test of multi-collinearity for anxiety and pain level, all tolerance values were <0.1 and VIF values were >10, within acceptable cutoffs. A multivariate linear regression was utilized to analyze the association between the PSI total score and three domains and the predictor variables of demographics, smoking status, anxiety, depression, and pain severity. All variables were entered in a backwards entry procedure, entering smoking status in Block 1, demographics in Block 2, psychiatric symptoms in Bock 3, and pain severity in Block 4. A multivariate linear regression was also run with all variables entered in together (see Supplemental Tables). Analyses were run without and then with a Holm-Bonferroni adjustment.

Results

Sample Characteristics

Over two hundred participants were approached over the four-month recruitment period. The major reason for exclusion was no current smoking. One hundred fourteen participants completed oral consent procedures. Thirteen participants did not meet the inclusion criteria resulting in an analytic sample of n=101. See Table 1 for demographic and smoking characteristics for the full sample and by smoking status.

Table 1:

Demographic and smoking characteristics of the full sample of persons living with HIV who smoke cigarettes and for heavy versus light smokers.




Characteristics
Total Sample
(n=101)
M (SD) or %(N)
Light Smokersa
(n=76)
M (SD) or %(N)
Heavy Smokersa
(n=25)
M (SD) or %(N)


p-valueb
Age (years) 49.55 (8.81) 49.13 (9.08) 50.84 (7.95) 0.403
Gender (male) 50.5% (51) 48.7% (37) 56.0% (14) 0.526
Ethnicity (Latino/a) 54.4% (49) 51.5% (35) 63.6% (14) 0.319
Race (African American) 47.9% (45) 53.5% (38) 30.4% (7) 0.200
Sexual Orientation
  Heterosexual 72.4% (71) 69.9% (51) 80.0% (20)
  Homosexual 18.4% (18) 17.8% (13) 20.0% (5) 0.335
  Bisexual 8.20% (8) 11.0% (8) 0.0% (0)
  Education
  1st-8th Grade 7.2% (7) 4.2% (4) 16.0% (4)
  9th-11th Grade 27.8% (27) 31.9% (23) 16.0% (4) 0.002
  High School or GED 37.1% (36) 31.9% (23) 52.0% (13)
  Some College or College or Junior College 27.8% (27) 31.9% (23) 16.0% (4)
Years since HIV diagnosis 18.20 (7.20) 18.17 (7.11) 18.28 (7.60) 0.948
Smoking Behaviors
Smoking days per week 6.52 (2.48) 6.37 (2.84) 7.00 (0.00) 0.290
Using other tobacco products 11.0% (11) 12.0% (9) 8.0% (2) 0.580
Smoked ≥100 cigarettes in lifetime 92.9% (91) 91.9% (68) 95.8% (23) 0.515
Cigarettes per day (CPD) 9.55 (7.62) 6.08 (3.18) 20.10 (7.51) <0.001
Motivation to Quit (range=1-10)c 7.23 (2.75) 7.53 (2.62) 6.32 (2.97) 0.055
Confidence to Quit (range=1-10)c 5.92 (2.96) 6.04 (2.87) 5.56 (3.24) 0.485
Numeric Rating Scale for Pain (NRS; range=0-10) 4.60 (3.66) 4.50 (3.68) 4.88 (3.67) 0.656
Pain and Smoking Inventory total score (PSI; range=0-6) 2.01 (1.87) 1.90 (1.78) 2.32 (2.14) 0.343
Pain as a Motivator to Smoke 1.92 (2.09) 1.77 (2.02) 2.37 (2.25) 0.805
Smoking to Cope with Pain 2.16 (1.93) 2.13 (1.86) 2.24 (2.16) 0.343
Pain as Barrier to Quitting Smoking 1.94 (2.05) 1.81 (1.96) 2.33 (2.30) 0.272
PROMIS Depression Scale 53.08 (11.94) 52.14 (12.30) 56.38 (10.16) 0.152
PROMIS Anxiety Scale 56.99 (12.83) 57.05 (13.71) 56.82 (9.89) 0.940

Key: PROMIS, Patient-Reported Outcomes Measurement Information System

Notes: The total number of individuals reporting data for each characteristic differs from the N=101. Total response for each characteristic are as follows: Age, N= 101; Gender; N= 101; Ethnicity, N=90, Race, N=94; Sexual Orientation, N= 98; Education, N=97; Years of HIV diagnosis, N=96;Smoking Days per a week, N=95; Use of other Tobacco products, N=100; Smoking more 100 cigarettes, N=98; CPD, N=101; NRS, N=99; Pain and Smoking Inventory, N=101; Pain as a Motivator to Smoke, N=101; Smoking to Cope with Pain, N=101; Pain as Barrier to Quitting Smoking, N=101 PROMIS Depression Scale, N= 95; PROMIS Anxiety scale, N=98; Feels about Quitting, N=100; Confident about Quitting, N=100.

a

Light smokers were defined as those reporting smoking 1 to 10 cigarettes per day and heavy smokers were defined as those reporting smoking 11 or more cigarettes per a day.

b

Light smokers versus heavy smokers

c

Higher scores indicated greater motivation or confidence to quit smoking

Association of demographic and smoking variables to the PSI (Supplemental Tables 1-4)

Greater anxiety symptoms (β =0.056, SE=0.015 p<0.001) and greater current pain severity (β =0.226, SE=0.050, p<0.001) were significantly associated with a higher total PSI score after controlling for smoking status, demographics, and depression symptoms. Smoking status, demographics, and depression symptoms were not significantly associated with the total PSI score.

With regard to the PSI domains, greater anxiety symptoms (β=0.063, SE=0.018, p=<0.001) and greater current pain severity level (β=0.221, SE=0.060, p<0.001) were significantly associated with greater endorsement of pain as a motivator for smoking. Greater anxiety symptoms (β=0.059, SE=0.016, p<0.001) and greater current pain severity level (β=0.239, SE=0.053, p<0.001) were also significantly associated with higher endorsement of smoking to cope with pain. Finally, greater anxiety symptoms (β=0.048, SE=0.018, p=0.008), greater current pain severity level (β=−0.075, SE=0.033, p=0.010), and the length of time since the HIV diagnosis (β=0.166, SE=0.062, p=0.028) were associated with greater endorsement of pain being a barrier to stopping smoking. When the Holm-Bonferroni adjustment was run, the significant relationships remained the same except that the results for the pain as barrier to quitting smoking domain were no longer significant.

Discussion

The current study was the first to examine factors associated with perceived interactions of pain and smoking among PLWH who smoke cigarettes. Pain severity, anxiety symptoms, and length of time since HIV diagnosis were each related to aspects of the perceived interrelations of pain and smoking. First, greater current pain severity was related to greater endorsement of overall perceived interrelations between pain and smoking, pain as a motivator for smoking, and smoking to cope with pain. Second, greater anxiety symptoms were associated with greater endorsement of overall perceived interrelations between pain and smoking, pain as a motivator for smoking, and smoking to cope with pain. While pain severity, anxiety, and HIV diagnosis length were originally associated with pain as a barrier for smoking cessation, these associations were no longer significant after a correction for multiple comparisons.

People who smoke and report pain also report less confidence in their ability to quit smoking and have greater expectations that quitting smoking will be difficult (Ditre, Kosiba, Zale, Zvolensky, & Maisto, 2016; Zale, Ditre, Dorfman, Heckman, & Brandon, 2014). Futhremore, pain is a predictor for relapse in smoking cessations program (Aigner, Gritz, Tami-Maury, Baum, Arduino, & Vidrine, 2017). Being able to identify barriers to smoking cessation are vital for creating more effective interventions. Ditre and collegues (2018) found that indiviudals who received a personalized intervention targeting pain had better smoking cessation outcomes than those who did not receive pain and smoking information. Future research can target these factors (e.g., pain severity, pain anxiety, the use of smoking to help manage pain) to improve quit outcomes for PLWH.

This study had a number of limitations. First, participants may have not been honest with their self-report or been impacted by recall biases. Second, the study had a relatively small sample. Third, results may not generalize to other PLWH due to the demographics of the sample.

Conclusions

Understanding the beliefs about the relationship between smoking and pain, as well as associated factors such as anxiety and pain severity, may help to guide interventions for PLWH who smoke.

Supplementary Material

Supp 1

Acknowledgments

The authors thank Alyssa Burns, Brittlyn Katz Pearlman, Christine Lee, and Kate Segal for their help with data collection.

Grant funding

This work was funded by the National Institutes of Health (NIH) under grants R01-DA036445, R01-CA192954, R34-DA037042, and K23-NS096107 and the Einstein-Rockefeller-CUNY Center for AIDS Research; which is supported by the following NIH co-funding and participating institutes and centers: NIAID, NCI, NICHD, NHBL, NIDA, NIMH, NIA, FIC and OAR; under grant P30-AI124414.

Footnotes

Conflicts of interest

The authors have no conflicts of interest to report

Contributor Information

Hannah Esan, Email: Hannah.esan@gmail.com.

Josh Agress, Email: agressj0@rowan.edu.

Elizabeth K. Seng, Email: Elizabeth.Seng@einstein.yu.edu.

Jonathan Shuter, Email: jshuter@montefiore.org.

Andrea H. Weinberger, Email: andrea.weinberger@einstein.yu.edu.

References

  1. ADAA. (2016). Chronic Pain. www.ADAA.org [Google Scholar]
  2. Ahmadi M, Kiakojori A, & Moudi S (2018). Association of anxiety with pain perception following periodontal flap surgery. Journal of the International Society of Preventive & Community Dentistry, 8(1), 28–33. doi: 10.4103/jispcd.JISPCD_385_17 [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Aigner CJ, Gritz ER, Tamí-Maury I, Baum GP, Arduino RC, & Vidrine DJ (2017). The role of pain in quitting among human immunodeficiency virus (HIV)–positive smokers enrolled in a smoking cessation trial. Substance Abuse, 38(3), 249–252. doi: 10.1080/08897077.2017.1291466 [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Barnett LA, Pritchard MG, Edwards JJ, Afolabi EK, Jordan KP, Healey EL, Dziedzic KS (2018). Relationship of anxiety with joint pain and its management: A population survey. Musculoskeletal Care, 16(3), 353–362. doi: 10.1002/msc.1243 [DOI] [PubMed] [Google Scholar]
  5. Brandt C, Zvolensky MJ, Woods SP, Gonzalez A, Safren SA, & O’Cleirigh CM (2017). Anxiety symptoms and disorders among adults living with HIV and AIDS: A critical review and integrative synthesis of the empirical literature. Clinical Psychology Review, 51, 164–184. doi: 10.1016/j.cpr.2016.11.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Brandt CP, Zvolensky MJ, Daumas SD, Grover KW, & Gonzalez A (2016). Pain-related anxiety in relation to anxiety and depression among persons living with HIV/AIDS. AIDS Care, 28(4), 432–435. doi: 10.1080/09540121.2015.1100704 [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. CDC. (2009). Cigarette smoking among adults and trends in smoking cessation - United States, 2008. Morbidity and Mortality World Report (MMWR), 58(44), 1227–1232. [PubMed] [Google Scholar]
  8. CDC. (2015). National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention.
  9. Cella D, Riley W, Stone A, et al. (2010). The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005-2008. Journal of Clinical Epidemiology, 63(11), 1179–1194. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Ditre JW, Kosiba JD, Zale EL, Zvolensky MJ, & Maisto SA (2016). Chronic pain status, nicotine withdrawal, and expectancies for smoking cessation among lighter smokers. Annals of Behavioral Medicine, 50(3), 427–435. doi: 10.1007/s12160-016-9769-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Ditre JW, LaRowe LR, Vanable PA, De Vita MJ, & Zvolensky MJ (2018). Computer-based personalized feedback intervention for cigarette smoking and prescription analgesic misuse among persons living with HIV (PLWH). Behaviour Research and Therapy, doi: 10.1016/j.brat.2018.10.013 [Epub ahead of print] [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Ditre JW, Zale EL, Heckman BW, & Hendricks PS (2017). A measure of perceived pain and tobacco smoking interrelations: Pilot validation of the pain and smoking inventory. Cognitive Behaviour Therapy, 46(4), 339–351. doi: 10.1080/16506073.2016.1256347 [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Ferraz MB, Quaresma MR, Aquino LR, Atra E, Tugwell P, & Goldsmith CH (1990). Reliability of pain scales in the assessment of literate and illiterate patients with rheumatoid arthritis. The Journal of Rheumatology, 17(8), 1022–1024. [PubMed] [Google Scholar]
  14. Hall SM, Havassy BE, Wasserman DA (1991). Effects of commitment to abstinence, positive moods, stress, and coping on relapse to cocaine use. Journal of Consulting and Clinical Psychology, 59, 526–532. [DOI] [PubMed] [Google Scholar]
  15. Hawker GA, Mian S, Kendzerska T, & French M (2011). Measures of adult pain: Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ), Short-Form McGill Pain Questionnaire (SF-MPQ), Chronic Pain Grade Scale (CPGS), Short Form-36 Bodily Pain Scale (SF-36 BPS), and Measure of Intermittent and Constant Osteoarthritis Pain (ICOAP). Arthritis Care & Research, 63(S11), S240–S252. doi: 10.1002/acr.20543 [DOI] [PubMed] [Google Scholar]
  16. Huggins JL, Bonn-Miller MO, Oser ML, Sorrell JT, & Trafton JA (2012). Pain anxiety, acceptance, and outcomes among individuals with HIV and chronic pain: a preliminary investigation. Behaviour Resesarch and Therapy, 50(1), 72–78. doi: 10.1016/j.brat.2011.10.008 [DOI] [PubMed] [Google Scholar]
  17. Levin JB, Aebi ME, Smyth K, Tatsuoka C, Sams J, Scheidemantel T, & Sajatovic M (2015). Comparing PROMIS to legacy depression measures in a community sample of older adults with varying levels of cognitive functioning. The American Journal of Geriatric Psychiatry, 23(11), 1134–1143. doi: 10.1016/j.jagp.2015.04.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Mdodo R, Frazier EL, Dube SR, Mattson CL, Sutton MY, Brooks JT, & Skarbinski J (2015). Cigarette smoking prevalence among adults with HIV compared with the general adult population in the United States: cross-sectional surveys. Annals of Internal Medicine, 162(5), 335–344. doi: 10.7326/m14-0954 [DOI] [PubMed] [Google Scholar]
  19. Merlin JS, Bulls HW, Vucovich LA, Edelman EJ, & Starrels JL (2016). Pharmacologic and non-pharmacologic treatments for chronic pain in individuals with HIV: A systematic review. AIDS Care, 28(12), 1506–1515. doi: 10.1080/09540121.2016.1191612 [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Merlin JS, Westfall AO, Raper JL, Zinski A, Norton WE, Willig JH, … Mugavero MJ (2012). Pain, mood, and substance abuse in HIV: Implications for clinic visit utilization, ART adherence, and virologic failure. Journal of Acquired Immune Deficiency Syndromes, 61(2), 164–170. doi: 10.1097/QAI.0b013e3182662215 [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Moylan S, Jacka FN, Pasco JA, & Berk M (2012). Cigarette smoking, nicotine dependence and anxiety disorders: A systematic review of population-based, epidemiological studies. BMC Medicine, 10, 123. doi: 10.1186/1741-7015-10-123 [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Orhurhu VJ, Pittelkow TP, & Hooten WM (2015). Prevalence of smoking in adults with chronic pain. Tobacco Induced Diseases, 13(1), 17. doi: 10.1186/s12971-015-0042-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Park LS, Hernandez-Ramirez RU, Silverberg MJ, Crothers K, & Dubrow R (2016). Prevalence of non-HIV cancer risk factors in persons living with HIV/AIDS: A meta-analysis. AIDS, 30(2), 273–291. doi: 10.1097/QAD.0000000000000922 [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Parker R, Stein DJ, & Jelsma J (2014). Pain in people living with HIV/AIDS: A systematic review. Journal of the International AIDS Society, 17(1), 18719. doi: 10.7448/IAS.17.1.18719 [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Perkins KA, Marcus MD, Levine MD, D’Amico D, Miller A, Broge M, Ashcom J, Shiffman S (2001). Cognitive-behavioral therapy to reduce weight concerns improves smoking cessation outcome in weight-concerned women. Journal of Consulting & Clinical Psychology, 69(4), 604–613. [PubMed] [Google Scholar]
  26. Pilkonis PA, Choi SW, Reise SP, Stover AM, Riley WT, & Cella D (2011). Item banks for measuring emotional distress from the Patient-Reported Outcomes Measurement Information System (PROMIS®): Depression, Anxiety, and Anger. Assessment, 18(3), 263–283. doi: 10.1177/1073191111411667 [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Schane RE, Ling PM, & Glantz SA (2010). Health effects of light and intermittent smoking: A review. Circulation, 121(13), 1518–1522. doi: 10.1161/CIRCULATIONAHA.109.904235 [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Stanton CA, Moadel AB, Kim RS, Weinberger AH, & Shuter J (2015). Loneliness in HIV-infected smokers. AIDS Care, 27(2), 268–272. doi: 10.1080/09540121.2014.963017 [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Tsao JC, Plankey MW, & Young MA (2012). Pain, psychological symptoms and prescription drug misuse in HIV: A literature review. Journal of Pain Management, 5(2), 111–118. [PMC free article] [PubMed] [Google Scholar]
  30. USDHHS. (2013). AIDS. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. [Google Scholar]
  31. USDHHS. (2014). The Health Consequences of Smoking—50 Years of Progress: A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2014; Printed with corrections, January 2014. [Google Scholar]
  32. Vidrine DJ, Kypriotakis G, Li L, Arduino RC, Fletcher FE, Tamí-Maury I, & Gritz ER (2015). Mediators of a smoking cessation intervention for persons living with HIV/AIDS. Drug and Alcohol Dependence, 147, 76–80. doi: 10.1016/j.drugalcdep.2014.12.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Warner KE (2015). The remarkable decrease in cigarette smoking by American youth: Further evidence. Preventive Medicine Reports, 2, 259–261. doi: 10.1016/j.pmedr.2015.04.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Weinberger AH, Seng EK, Ditre JW, Willoughby M, & Shuter J (2018). Perceived interrelations of pain and cigarette smoking in a sample of adult smokers living with HIV/AIDS. Nicotine & Tobacco Research. doi: 10.1093/ntr/nty021 [epub ahead of print] [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Yi Z, Mayorga ME, Hassmiller Lich K, & Pearson JL (2017). Changes in cigarette smoking initiation, cessation, and relapse among U.S. adults: a comparison of two longitudinal samples. Tobacco Induced Diseases, 15, 17. doi: 10.1186/s12971-017-0121-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Zale EL, Ditre JW, Dorfman ML, Heckman BW, & Brandon TH (2014). Smokers in pain report lower confidence and greater difficulty quitting. Nicotine & Tobacco Research, 16(9), 1272–1276. doi: 10.1093/ntr/ntu077 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supp 1

RESOURCES